Canada Markets closed

Those Who Purchased Khiron Life Sciences (CVE:KHRN) Shares A Year Ago Have A 29% Loss To Show For It

Simply Wall St

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. For example, the Khiron Life Sciences Corp. (CVE:KHRN) share price is down 29% in the last year. That contrasts poorly with the market return of 2.8%. Khiron Life Sciences may have better days ahead, of course; we've only looked at a one year period. In the last ninety days we've seen the share price slide 44%.

View our latest analysis for Khiron Life Sciences

Khiron Life Sciences isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. When a company doesn't make profits, we'd generally expect to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.


You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

TSXV:KHRN Income Statement, September 26th 2019

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. You can see what analysts are predicting for Khiron Life Sciences in this interactive graph of future profit estimates.

A Different Perspective

While Khiron Life Sciences shareholders are down 29% for the year, the market itself is up 2.8%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Notably, the loss over the last year isn't as bad as the 44% drop in the last three months. This probably signals that the business has recently disappointed shareholders - it will take time to win them back. Investors who like to make money usually check up on insider purchases, such as the price paid, and total amount bought. You can find out about the insider purchases of Khiron Life Sciences by clicking this link.

Khiron Life Sciences is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.